[go: up one dir, main page]

WO1998009514A1 - Solutions de vitrification servant a conserver a long terme des cellules, des tissus, des organes et des organismes - Google Patents

Solutions de vitrification servant a conserver a long terme des cellules, des tissus, des organes et des organismes Download PDF

Info

Publication number
WO1998009514A1
WO1998009514A1 PCT/US1997/015611 US9715611W WO9809514A1 WO 1998009514 A1 WO1998009514 A1 WO 1998009514A1 US 9715611 W US9715611 W US 9715611W WO 9809514 A1 WO9809514 A1 WO 9809514A1
Authority
WO
WIPO (PCT)
Prior art keywords
permeating
cryoprotectant
cell
rehydration
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1997/015611
Other languages
English (en)
Inventor
Victor Bronshtein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universal Preservation Technologies Inc
Original Assignee
Universal Preservation Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universal Preservation Technologies Inc filed Critical Universal Preservation Technologies Inc
Priority to IL12885597A priority Critical patent/IL128855A0/xx
Priority to EP97940831A priority patent/EP0932337A4/fr
Priority to AU42520/97A priority patent/AU4252097A/en
Priority to JP10512916A priority patent/JP2001502664A/ja
Publication of WO1998009514A1 publication Critical patent/WO1998009514A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators

Definitions

  • This invention relates to the long-term shelf preservation of cells and multicellular specimens by vitrification.
  • the invention is directed to the optimization of vitrification and rehydration solutions, as well as vitrification, and rehydration procedures.
  • Vitrification is an alternative approach to cryopreservation that utilizes solidification of samples during cooling, without formation of ice crystals (Fahy, G.M. et al . , 1984). Conventionally, cryopreservation by vitrification of single cell
  • Ice formation at low temperatures can be avoided only if samples are sufficiently dehydrated.
  • Dehydration is known to damage cells.
  • the damaging effect of dehydration increases with increasing osmotic pressure (concentration) and depends strongly upon whether the vitrification solution contains permeating cryoprotectants.
  • concentration osmotic pressure
  • cells normally cannot survive equilibration in solutions containing only non-permeating solutes in concentration >1 mol/1.
  • many types of cells can easily tolerate equilibration in solutions containing permeating cryoprotectants in much higher concentrations. This is because penetration of cryoprotectants protects cells against dehydration damage.
  • dehydration does not mean a decrease in the cell volume which actually may be very damaging (Meryman, H.T., 1967, Meryman, H.T., 1970) .
  • the term "dehydration” means removal of water, or increase in the osmotic pressure. Erroneous use of this term resulted in several misconceptions. For example, as described below, dehydration by itself is not a strong damaging factor. Dehydration may even be a protective factor, as performed according to the present invention.
  • cryoprotectants help to vitrify cytosol, and the fact that some intracellular cryoprotectant is required to protect cells during dehydration, penetration of cryoprotectant inside cells may be considered as a beneficial phenomena.
  • a negative aspect of this penetration, considered in the literature, is associated with direct chemical toxicity of cryoprotectants (Fahy et al . , 1990). Because the toxicity is believed to be proportional to the concentration of cryoprotectants (not to the amount of cryoprotectants inside a cell) three basic approaches have been proposed to minimize the toxicity (for details see review of Steponkus, P.L. et al . , 1992): 1. to use a mixture of different cryoprotectants ;
  • thermodynamic force responsible for cryoprotectant permeation inside cells is proportional to the cryoprotectant concentration gradient across the cell membrane independent of the composition of the vitrification solution.
  • Bronshteyn, V.L. et al . (1994) found that amino acids (glycine and glutamic acid) and carbohydrates (sucrose and sorbitol) significantly diminished ethylene glycol permeation inside Drosophila melanogaster embryos.
  • the preventive effect of amino acids was impressive because 1 wt% of glutamic acid + 0.5 wt% glycine practically prevented ethylene glycol permeation inside embryos for up to three hours of equilibration in vitrification solution containing 42 wt% ethylene glycol.
  • an object of the present invention to provide a preservation method and a cryoprotectant for cryopreserving cells and multicellular specimens that accounts for the newfound facts that use of low molecular weight cryoprotectants can be detrimental to the cryopreserva ion process. It is a further object of the present invention to provide a preservation method and a vitrification solution for preserving by vitrification extracellular spaces in the specimen.
  • the present invention is directed to a method of preserving cells or multicellular specimens including the step of contacting the specimen with a vitrification solution comprising a permeating cryoprotectant, a non- permeating cryoprotectant and a non-permeating co-solute that limits the amount of the permeating cryoprotectant that permeates the specimen.
  • the method further includes the step of unloading the specimen by contacting the loaded specimen with a rehydration solution comprising a non- permeating co-solute and, optionally, a permeating cryoprotectant and a non-permeating rehydration cryoprotectant, such that cryoprotectant is removed from the cells of the specimen.
  • the cryoprotectants can be loaded or unloaded in a stepwise manner, in a linear manner, or according to a desired profile .
  • the present invention is also directed to the vitrification and rehydration solutions for use in connection with the method described above.
  • the present invention is directed to a method for preserving a biological specimen and compositions for achieving the same.
  • Suitable specimens can be single cells
  • erythocyte erythocyte, stem cells, sperm, E. Coli , yeasts and other cellular microorganisms, etc.
  • multicellular tissues erythocyte, stem cells, sperm, E. Coli , yeasts and other cellular microorganisms, etc.
  • vitrification solutions and rehydration solutions described herein minimize toxicity of the vitrification and rehydration solutions and increase intracellular and extracellular vitrification temperatures.
  • the method includes the step of contacting a specimen or sample with a cryopreservation or vitrification solution.
  • the cryopreservation solution includes a permeating (i.e., low molecular weight) cryoprotectant, a non-permeating (i.e., high molecular weight) cryoprotectant and a non-permeating co-solute that effectively decrease the chemical potential of penetrating cryoprotectants in the vitrification solution. Addition of high molecular weight non-permeating cryoprotectants will increase the vitrification temperature of the cryopreservation solution outside cells.
  • the co-solutes will limit the amount of permeating cryoprotectants that move inside cells and therefore increase the mass/mass ratio of intracellular protein to permeating cryoprotectant in a dehydrated specimen in cryopreservation solution. This will increase the intracellular vitrification temperature for a given osmotic pressure of cryopreservation solution.
  • some minimum amount of cryoprotectant is required inside the cells of the specimen in order to protect the cells against dehydration.
  • the maximum concentration of co-solutes that can be added to cryopreservation solution, to limit penetration of cryoprotectant inside cells depends upon the minimum amount of cryoprotectant required to protect cells against dehydration in cryopreservation solution.
  • the maximum concentration of co-solutes can be found experimentally for every specific type of permeating cryoprotectants, osmotic pressure of cryopreservation solution, type of co-solute and type of specimen.
  • cryopreservation solution should contain high molecular weight cryoprotectants, such as dextrans, starches, polyethylene glycol, polyvinylpyrrolidone, Ficol, peptides, etc.
  • Co-solutes that decrease the chemical potential of penetrating cryoprotectants in aqueous solutions include, but are not limited to:
  • Amino acids glycine, alanine, glutamic acid, proline, valine, hydroxy-1-proline, beta- aminopropionic acid, a inobutyric acid, beta-ainocaproic acid, aminoisobutyric acid, N-methylglycine, norvaline, and others that are soluble in water in concentration >0.1 mol/1, and derivatives of amino acids (sarcosine, i inodiacetic acid, hydroxyethyl glycine, etc.) that are soluble in water in concentration >0.1 mol/1.
  • Betaines betaine and other betaines that are soluble in water in concentration >0.1 mol/1.
  • Carbohydrates monosaccharide (aldose and ketoses) glyceraldehyde , lyxose, ribose, xylose, galactose, glucose, hexose, mannose, talose, heptose, dihydroxyacetone, pentulose, hexulose, heptulose, octulose, etc., and their derivatives a.
  • Amino sugars D-ribose , 3-amino-3 -deoxy- , chitosamine, fucosamine, etc.; b.
  • Alditols and inositols glycerol, erythritol, arabinitol, ribitol, mannitol, iditol, betitol, inositol , etc . ; c. Aldonic, uronic, and aldaric acids that are soluble in water in concentration >0.1 mol/1.; and d. disaccharides (sucrose, trehalose, etc.). 4. Sugar alcohols (sorbitol, etc.) .
  • the cells should be substantially dehydrated.
  • the dehydration damages the cells due to large repulsive forces between macromolecules inside cells.
  • a small amount of cryoprotectant should be present inside cells in order to decrease these forces.
  • the amount of cryoprotectant inside the cells should be kept as low as possible to decrease the toxic effect of the vitrification solution and to increase the intracellular vitrification temperature. All these requirements can be achieved by using cryopreservation solution that contain mixtures of permeating (i.e., low molecular weight) and non-permeating
  • cryoprotectants along with non-permeating co-solutes (amino acids, betaines, sugars, etc. in concentrations from 0.1 - 0.6 mol/1) that effectively decrease the chemical potential of penetrating cryoprotectants in cryopreservation solution.
  • cells can be stored at a temperature that is lower than the vitrification temperatures both inside and outside the cells of the specimen.
  • cells Prior to dehydration, cells may be loaded in a low concentration (5-40 wt%) , non-damaging solution of permeating cryoprotectant to protect cells from damage during dehydration in cryopreservation solution.
  • intracellular cryoprotectant should be removed from the cells and exchanged for water. It is believed that damage during rehydration, when cells are transferred from cryopreservation (vitrification) solution to a rehydration (washing) solution, occurs because of an increase in cellular volume beyond initial cellular volumes. To avoid this possibility of damage, one has to include in rehydration solutions, co-solutes, as described above, such as: amino acids, betaines, carbohydrates, or other non- permeating co-solutes that effectively decrease the chemical potential of permeating cryoprotectants in aqueous solutions. The co-solutes are used in concentrations from 0.1 - 0.6 mol/1. Higher co-solute concentrations will more effectively limit the mass of intracellular cryoprotectants, however, when this mass gets very small, the dehydrated cells may be damaged.
  • the invention allows one to significantly decrease the osmotic pressure of vitrification solution required to obtain a stable vitrification of cells during cooling, to significantly increase extracellular and intracellular vitrification temperatures and the time of cell equilibration (dehydration) in the vitrification solution, without increasing cell damage.
  • This allows one to solve many related problems occurring during equilibration in vitrification solution, storage and rehydration and washing out of intracellular cryoprotectant .
  • the amounts of permeating cryoprotectant and other components of the cryopreservation solution may be increased in the cryopreservation solution in a stepwise fashion, a linear fashion or according to a desired profile from an initial concentration ( ⁇ 0%) to an optimal final concentration.
  • the cryopreservation solution and the relative amounts of components thereof may be controlled mechanically or manually. Similarly, to optimize the rehydration process, the contents of the rehydration solution and timing of the rehydration process can be similarly controlled.
  • the optimal initial and final concentrations, as well as the optimum method for increasing the relative concentrations of the components of the cryopreservation and rehydration solutions is determined empirically.
  • osmotic pressure gradients arising during dehydration of multicellular specimens can be decreased. This is a very important matter because if a portion of cells in the sample is less dehydrated than other portions, it may freeze during subsequent cooling and be damaged .
  • the method of the present invention encompasses dehydration of specimens, cooling samples to a storage temperature, warming of the samples to ambient temperature, rehydration and washing out of cryoprotectants in rehydration solution, and returning to normal physiological conditions for various medical procedures (transfusions, transplantation, etc.).
  • Steponkus P.L., Langis, R. and Fujikawa, S. 1992. Cryopreservation of plant tissues by vitrification. In: Advances in Low-Tempera ture Biology, Vol. 1, edited by P.L. Steponkus. pp. 1-61. JAI Press, Ltd., London.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Dentistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Le procédé de conservation par vitrification décrit dans cette demande permet de stocker des échantillons à des températures supérieures à celles utilisées dans les procédés classiques et peut être appliqué à des cellules, des organes, des organismes et des tissus multicellulaires. Le procédé de cette invention consiste à préparer une solution de co-solutés non perméables de vitrification (acides aminés, betaïnes, glucides ou autres co-solutés non perméables qui réduisent efficacement le potentiel chimique de cryoprotecteurs à perméation dans des solutions aqueuses), un cryoprotecteur à perméation et un cryoprotecteur non perméable (polyvinyl-pyrrolidone, polyéthylène glycol, dextrane, amidon d'hydroxy éthyle, Ficol, etc...); à mettre un échantillon en contact avec la solution de vitrification et à stocker l'échantillon à une température de stockage. Le procédé comprend également une étape de réhydratation de l'échantillon conservé dans une solution de réhydratation préparée de la même manière que la solution de stockage par vitrification. Cette invention concerne également une solution de vitrification et une solution de réhydratation telles que cells décrites dans le procédé.
PCT/US1997/015611 1996-09-06 1997-09-05 Solutions de vitrification servant a conserver a long terme des cellules, des tissus, des organes et des organismes Ceased WO1998009514A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IL12885597A IL128855A0 (en) 1996-09-06 1997-09-05 Vitrification solutions for shelf preservation of cells tissues organs and organisms
EP97940831A EP0932337A4 (fr) 1996-09-06 1997-09-05 Solutions de vitrification servant a conserver a long terme des cellules, des tissus, des organes et des organismes
AU42520/97A AU4252097A (en) 1996-09-06 1997-09-05 Vitrification solutions for shelf preservation of cells, tissues, organs and organisms
JP10512916A JP2001502664A (ja) 1996-09-06 1997-09-05 細胞、組織、器官及び生物体の貯蔵保存用ガラス化溶液

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2557096P 1996-09-06 1996-09-06
US60/025,570 1996-09-06

Publications (1)

Publication Number Publication Date
WO1998009514A1 true WO1998009514A1 (fr) 1998-03-12

Family

ID=21826828

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/015611 Ceased WO1998009514A1 (fr) 1996-09-06 1997-09-05 Solutions de vitrification servant a conserver a long terme des cellules, des tissus, des organes et des organismes

Country Status (5)

Country Link
EP (1) EP0932337A4 (fr)
JP (1) JP2001502664A (fr)
AU (1) AU4252097A (fr)
IL (1) IL128855A0 (fr)
WO (1) WO1998009514A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003009743A2 (fr) 2001-07-26 2003-02-06 21St Century Medicine, Inc. Reduction hypertonique d'accidents causes par refrigeration
EP1283670A4 (fr) * 2000-05-16 2003-09-17 Gen Hospital Corp Micro-injection de cytoprotecteurs pour la conservation des cellules
US7094601B2 (en) 2000-05-16 2006-08-22 The General Hospital Corporation Microinjection of cryoprotectants for preservation of cells
WO2012067240A1 (fr) 2010-11-19 2012-05-24 セーレン株式会社 Solution de stockage vitrifiée pour des cellules
WO2013096659A1 (fr) * 2011-12-20 2013-06-27 Cook General Biotechnology Llc Procédés et compositions pour le stockage de cellules animales

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980277A (en) * 1987-10-16 1990-12-25 Cultor Ltd. Cryoprotectant solution and method
US5160313A (en) * 1991-05-14 1992-11-03 Cryolife, Inc. Process for preparing tissue for transplantation
US5217860A (en) * 1991-07-08 1993-06-08 The American National Red Cross Method for preserving organs for transplantation by vitrification
US5364756A (en) * 1990-09-12 1994-11-15 Lifecell Method of cryopreserving a suspension of biological material

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559298A (en) * 1982-11-23 1985-12-17 American National Red Cross Cryopreservation of biological materials in a non-frozen or vitreous state
US4865871A (en) 1983-08-23 1989-09-12 Board Of Regents The University Of Texas System Method for cryopreparing biological tissue
US5145770A (en) * 1990-06-04 1992-09-08 Biosurface Technology, Inc. Cryopreservation of cultured epithelial sheets
IT1256621B (it) * 1992-12-04 1995-12-12 Soluzioni crioprotettrici

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980277A (en) * 1987-10-16 1990-12-25 Cultor Ltd. Cryoprotectant solution and method
US5364756A (en) * 1990-09-12 1994-11-15 Lifecell Method of cryopreserving a suspension of biological material
US5160313A (en) * 1991-05-14 1992-11-03 Cryolife, Inc. Process for preparing tissue for transplantation
US5217860A (en) * 1991-07-08 1993-06-08 The American National Red Cross Method for preserving organs for transplantation by vitrification

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HUMAN REPRODUCTION, 1995, Vol. 10, No. 3, TITTERINGTON et al., "Synthetic and Biological Macromolecules: Protection of Mouse Embryos During Cryopreservation by Vitrification", pages 649-653. *
JOURNAL OF REPRODUCTION AND FERTILITY, 1994, Vol. 101, RALL et al., "High In Vitro and In Vivo Survival of Day 3 Mouse Embryos Vitrified or Frozen in a Non-Toxic Solution of Glycerol and Albumin", pages 681-688. *
See also references of EP0932337A1 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1283670A4 (fr) * 2000-05-16 2003-09-17 Gen Hospital Corp Micro-injection de cytoprotecteurs pour la conservation des cellules
US6673607B2 (en) 2000-05-16 2004-01-06 Mehmet Toner Microinjection of cryoprotectants for preservation of cells
US7094601B2 (en) 2000-05-16 2006-08-22 The General Hospital Corporation Microinjection of cryoprotectants for preservation of cells
WO2003009743A2 (fr) 2001-07-26 2003-02-06 21St Century Medicine, Inc. Reduction hypertonique d'accidents causes par refrigeration
EP1422999A4 (fr) * 2001-07-26 2007-11-07 21St Century Medicine Inc Reduction hypertonique d'accidents causes par refrigeration
WO2012067240A1 (fr) 2010-11-19 2012-05-24 セーレン株式会社 Solution de stockage vitrifiée pour des cellules
EP2641966A4 (fr) * 2010-11-19 2014-04-30 Seiren Kabushiki Kaisha Solution de stockage vitrifiée pour des cellules
WO2013096659A1 (fr) * 2011-12-20 2013-06-27 Cook General Biotechnology Llc Procédés et compositions pour le stockage de cellules animales

Also Published As

Publication number Publication date
EP0932337A4 (fr) 1999-12-29
IL128855A0 (en) 2000-01-31
EP0932337A1 (fr) 1999-08-04
AU4252097A (en) 1998-03-26
JP2001502664A (ja) 2001-02-27

Similar Documents

Publication Publication Date Title
Trimeche et al. Effects of glutamine, proline, histidine and betaine on post-thaw motility of stallion spermatozoa
AU659795B2 (en) Composition to improve survival of biological materials
Rall Factors affecting the survival of mouse embryos cryopreserved by vitrification
NL193971C (nl) Perfusaat voor het conserveren van organen. Waterige samenstelling voor het conserveren en bewaren van organen.
Koshimoto et al. Effect of osmolality and oxygen tension on the survival of mouse sperm frozen to various temperatures in various concentrations of glycerol and raffinose
EP3403502A1 (fr) Composition cryoprotectrice et/ou cryo-conservatrice, ses procédés et utilisations
Molinia et al. Incorporation of penetrating cryoprotectants in diluents for pellet-freezing ram spermatozoa
CA2250084A1 (fr) Utilisation d'arabinogalactane dans des milieux de cryoconservation de cellules
AU2017340511B2 (en) Systems and methods for natural cryoprotectants for preservation of cells
US20020051963A1 (en) Shelf preservation of cells, tissues, organs and organisms by vitrification
Kim et al. A comparative study of the effects of glycerol and hydroxyethyl starch in canine red blood cell cryopreservation
WO1997045010A1 (fr) Charge et decharge de protecteurs a permeation pour la cryopreservation de cellules, de tissus et d'organes par vitrification
EP0932337A1 (fr) Solutions de vitrification servant a conserver a long terme des cellules, des tissus, des organes et des organismes
Santarius et al. Cryopreservation of spinach chloroplast membranes by low-molecular-weight carbohydrates: I. Evidence for cryoprotection by a noncolligative-type mechanism
WO1991012718A1 (fr) Cryoconservation amelioree a l'aide d'un peptide d'hysteresis thermique
US20040018482A1 (en) Loading and unloading of permeating protectants for cell, tissue, and organ cryopreservation by vitrification
Ristic et al. Mechanisms of freezing resistance of wood tissues: recent advancements
Chayen et al. Life-like preservation of cytoplasmic detail in plant cells
Mazur Principles of medical cryobiology: The freezing of living cells, tissues, and organs
Brockbank et al. Society for Cryobiology1'2
Woloszyn et al. Homograft viability, assessment and significance
Finkle et al. Effects of combinations of cryoprotectants on the freezing survival of sugarcane cultured cells
Hvozdiuk et al. Research in comparative aspect of cryoprotective action of glycerin-based cryopreservatives in combination with polyvinyl alcohol of different molecular weights at fast and slow cooling of human donor blood
CN117007400A (zh) 乙醇型冰冻切片组织固定液
WO1991013091A1 (fr) Cryoconservation de globules rouges

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 09254563

Country of ref document: US

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 512916

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1997940831

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1997940831

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1997940831

Country of ref document: EP